Chatham-Kent Clinical Trials Research Centre

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Bipolar disorder1 trial
• Depression1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Completed3 trials
• Terminated1 trial

Lead sponsor

• Biohaven Pharmaceuticals, Inc.2 trials
• Janssen Pharmaceutica N.V., Belgium1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial

Closed trials

• Completed

  A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

  NCT05593029· Phase 2· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Completed

  A Study of JNJ-55308942 in the Treatment of Bipolar Depression

  NCT05328297· Phase 2· Janssen Pharmaceutica N.V., Belgium· Source

• Terminated

  Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

  NCT04708834· Phase 3· Biohaven Pharmaceuticals, Inc.· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder

  NCT04693351· Phase 3· Biohaven Pharmaceuticals, Inc.· Source